Drug factory · FDA FEI 3008705620
Esteve Huayi Pharmaceutical Co., Ltd.
Linhai Rd., Yuecheng District, Shaoxing, China
Problems found, fixed voluntarily at FDA's last inspection, Mar 14, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
4 drug inspections on record since 2012: 1 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Brensocatib | Makes the active ingredient and tests it | Insmed Incorporated | 71558-001, 71558-002 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 14, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 23, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 20, 2015 | No problems found | Drug Quality Assurance | — |
| Jan 6, 2012 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.